Introduction Baxter 2021 Corporate Responsibility Report 5 2030 Corporate Responsibility Goals Corporate Responsibility Commitment Empower Our Patients Protect Our Planet Appendix Champion Our People and Communities Cross-Cutting Commitments INNOVATION Baxter and Hillrom are uniting to meet the challenges of a rapidly-evolving healthcare landscape. Our products and services are essential building blocks of health - care. We innovate to bring smarter, more personalized care to the world with new technologies and therapies for patients and providers. These efforts are bolstered by our partnerships with clinical experts and leaders in digital health and the broader healthcare industry who diversify our discovery process. We aspire to transform healthcare by helping providers improve care outcomes, enhance workflow efficiencies and enable more cost-effective healthcare solutions. With approximately 2 million "smart devices" 2 globally, we are advancing new solutions across the care continu - um, including device connectivity, data visualization and analytics tools, care communications, and monitoring and sensing innovations. Our goal is for our innovations to work together in a connected system that surrounds the patient and their care team. We are also transforming the way we operate by empowering our people to learn and innovate at scale using digital technology. Our goal is to help our people and our customers to reach their full potential by driving data, insights and deep partnerships to advance our mission of saving and sustaining lives. In 2021, our companywide digital transformation initiative led to new customer service and therapy support tools for patients and healthcare providers and new digital health solutions in clinical nutrition and home dialysis. We also deployed more than 20 new digital solutions internally to support our operations, from manufacturing planning to quality tracking and beyond. Baxter’s robust product pipeline is designed to help clinicians be more efficient and effective as they treat patients across multiple care settings, including the hospital bedside, operating room and intensive care unit; dialysis clinic; physician’s office and at home. We expect to introduce several innovations to help improve care for patients around the world, including digital health solutions for the hospital and home, a new infusion pump platform, a new digital-ready ophthalmoscope and otoscope to transform physical examinations, new developments in home dialysis technology, generic injectable drug offerings and more. Our approach to corporate responsibility supports our company’s goals to achieve top quartile results relative to industry peers and other comparators across four dimensions: Patient safety and Quality Growth through innovation Best place to work Industry-leading performance The content in the remainder of this report, including progress toward all of our 2030 Corporate Responsibility Goals, refers to Baxter and does not include Hillrom, unless stated otherwise. Our Baxter 2022 Corporate Responsibility Report will reflect the combined company. Photo: Baxter’s Sharesource remote patient management platform is the most widely adopted digital health platform for home dialysis globally. The platform allows healthcare professionals to remotely monitor and manage their home patients’ automated peritoneal dialysis treatments.